|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papa A, Caruso D, Tomao S, Rossi L,
Zaccarelli E and Tomao F: Triple-negative breast cancer:
Investigating potential molecular therapeutic target. Expert Opin
Ther Targets. 19:55–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Surazynski A, Miltyk W, Prokop I and Palka
J: The effect of estrogen on prolidase-dependent regulation of
HIF-1α expression in breast cancer cells. Mol Cell Biochem.
379:29–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Cancer Institute, . SEER fact
sheet for breast cancer. http://seer.cancer.gov/statfacts/html/breast.html.2005-2011
|
|
5
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai YP and Wu KJ: Hypoxia-regulated
target genes implicated in tumor metastasis. J Biomed Sci.
19:1022012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu ZJ, Semenza GL and Zhang HF:
Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang
Univ Sci B. 16:32–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agani F and Jiang BH: Oxygen-independent
regulation of HIF-1: Novel involvement of PI3K/AKT/mTOR pathway in
cancer. Curr Cancer Drug Targets. 13:245–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J,
Sun T, Wang J, Sun R and Liu Y: Hypoxia promotes vasculogenic
mimicry formation by inducing epithelial-mesenchymal transition in
ovarian carcinoma. Gynecol Oncol. 133:575–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He G, Jiang Y, Zhang B and Wu G: The
effect of HIF-1α on glucose metabolism, growth and apoptosis of
pancreatic cancerous cells. Asia Pac J Clin Nutr. 23:174–180.
2014.PubMed/NCBI
|
|
11
|
Lei J, Fan L, Wei G, Chen X, Duan W, Xu Q,
Sheng W, Wang K and Li X: Gli-1 is crucial for hypoxia-induced
epithelial-mesenchymal transition and invasion of breast cancer.
Tumour Biol. 36:3119–3126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dave JM and Bayless KJ: Vimentin as an
integral regulator of cell adhesion and endothelial sprouting.
Microcirculation. 21:333–344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chernoivanenko IS and Minin AA and Minin
AA: Role of vimentin in cell migration. Ontogenez. 44:186–202.
2013.(In Russian). PubMed/NCBI
|
|
14
|
Brown JM: Tumor hypoxia, drug resistance,
and metastases. J Natl Cancer Inst. 82:338–339. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Helmlinger G, Yuan F, Dellian M and Jain
RK: Interstitial pH and pO2 gradients in solid tumors in vivo:
High-resolution measurements reveal a lack of correlation. Nat Med.
3:177–182. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Song X, Wang X, Wei L, Liu X, Yuan
S and Lv L: Effect of chronic intermittent hypoxia on biological
behavior and hypoxia-associated gene expression in lung cancer
cells. J Cell Biochem. 111:554–563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Verduzco D, Lloyd M, Xu L, Ibrahim-Hashim
A, Balagurunathan Y, Gatenby RA and Gillies RJ: Intermittent
hypoxia selects for genotypes and phenotypes that increase
survival, invasion, and therapy resistance. PLoS One.
10:e1209582015. View Article : Google Scholar
|
|
18
|
Bhaskara VK, Mohanam I, Rao JS and Mohanam
S: Intermittent hypoxia regulates stem-like characteristics and
differentiation of neuroblastoma cells. PLoS One. 7:e309052012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi H, Gillespie DL, Berg S, Rice C,
Couldwell S, Gu J, Colman H, Jensen RL and Huang LE: Intermittent
induction of HIF-1α produces lasting effects on malignant
progression independent of its continued expression. PLoS One.
10:e1251252015.
|
|
20
|
Shen C, Beroukhim R, Schumacher SE, Zhou
J, Chang M, Signoretti S and Kaelin WG Jr: Genetic and functional
studies implicate HIF1α as a 14q kidney cancer suppressor gene.
Cancer Discov. 1:222–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miao ZF, Zhao TT, Wang ZN, Xu YY, Mao XY,
Wu JH, Liu XY, Xu H, You Y and Xu HM: Influence of different
hypoxia models on metastatic potential of SGC-7901 gastric cancer
cells. Tumour Biol. 35:6801–6808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi J, Wan Y and Di W: Effect of hypoxia
and re-oxygenation on cell invasion and adhesion in human ovarian
carcinoma cells. Oncol Rep. 20:803–807. 2008.PubMed/NCBI
|
|
23
|
Zhou W, Wang G, Zhao X, Xiong F, Zhou S,
Peng J, Cheng Y, Xu S and Xu X: A multiplex qPCR gene dosage assay
for rapid genotyping and large-scale population screening for
deletional α-thalassemia. J Mol Diagn. 15:642–651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu H, Wang D, Zhang L, Xie X, Wu Y, Liu
Y, Shao G and Su Z: Upregulation of autophagy by hypoxia-inducible
factor-1α promotes EMT and metastatic ability of CD133+ pancreatic
cancer stem-like cells during intermittent hypoxia. Oncol Rep.
32:935–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Almendros I, Wang Y and Gozal D: The
polymorphic and contradictory aspects of intermittent hypoxia. Am J
Physiol Lung Cell Mol Physiol. 307:L129–L140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pires IM, Bencokova Z, Milani M, Folkes
LK, Li JL, Stratford MR, Harris AL and Hammond EM: Effects of acute
versus chronic hypoxia on DNA damage responses and genomic
instability. Cancer Res. 70:925–935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zepeda AB, Pessoa A Jr, Castillo RL,
Figueroa CA, Pulgar VM and Farías JG: Cellular and molecular
mechanisms in the hypoxic tissue: Role of HIF-1 and ROS. Cell
Biochem Funct. 31:451–459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Noh MY, Kim YS, Lee KY, Lee YJ, Kim SH, Yu
HJ and Koh SH: The early activation of PI3K strongly enhances the
resistance of cortical neurons to hypoxic injury via the activation
of downstream targets of the PI3K pathway and the normalization of
the levels of PARP activity, ATP, and NAD+. Mol Neurobiol.
47:757–769. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen PY, Ho YR, Wu MJ, Huang SP, Chen PK,
Tai MH, Ho CT and Yen JH: Cytoprotective effects of fisetin against
hypoxia-induced cell death in PC12 cells. Food Funct. 6:287–296.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Toffoli S, Feron O, Raes M and Michiels C:
Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in
endothelial cells: Unravelling of a new PKA-dependent regulation of
HIF-1alpha. Biochim Biophys Acta. 1773:1558–1571. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mottet D, Dumont V, Deccache Y, Demazy C,
Ninane N, Raes M and Michiels C: Regulation of hypoxia-inducible
factor-1alpha protein level during hypoxic conditions by the
phosphatidylinositol 3-kinase/akt/glycogen synthase kinase 3beta
pathway in HepG2 cells. J Biol Chem. 278:31277–31285. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1)alpha: Its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Monti E and Gariboldi MB: HIF-1 as a
target for cancer chemotherapy, chemosensitization and
chemoprevention. Curr Mol Pharmacol. 4:62–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dewhirst MW: Intermittent hypoxia furthers
the rationale for hypoxia-inducible factor-1 targeting. Cancer Res.
67:854–855. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moeller BJ, Cao Y, Li CY and Dewhirst MW:
Radiation activates HIF-1 to regulate vascular radiosensitivity in
tumors: Role of reoxygenation, free radicals, and stress granules.
Cancer Cell. 5:429–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang IA, Oh MJ, Kim MH, Park SK, Kim BG
and Namgung U: Vimentin phosphorylation by Cdc2 in schwann cell
controls axon growth via β1-integrin activation. FASEB J.
26:2401–2413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen WC, Hsu KY, Hung CM, Lin YC, Yang NS,
Ho CT, Kuo SC and Way TD: The anti-tumor efficiency of
pterostilbene is promoted with a combined treatment of Fas
signaling or autophagy inhibitors in triple negative breast cancer
cells. Food Funct. 5:1856–1865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakajima E, Hammond KB, Rosales JL,
Shearer TR and Azuma M: Calpain, not caspase, is the causative
protease for hypoxic damage in cultured monkey retinal cells.
Invest Ophthalmol Vis Sci. 52:7059–7067. 2011. View Article : Google Scholar : PubMed/NCBI
|
